PRESENTATION · Dec 2023 · PDF
Acoramidis - AHA 2023 - Clinical Outcome Improvements
PRESENTATION · Dec 2023 · PDF
Infigratinib - ESPE 2023 - Updated Six Month Results in Phase 2 Cohort 5 Study
PRESENTATION · Dec 2023 · PDF
ADH1 - ASHG 2023 Novel Variants of the CaSR
PRESENTATION · Dec 2023 · PDF
BBP-418 - WMS 2023 - Phase 2 Data at 21 Months; Ambulatory Improvements at 9 Months
PRESENTATION · Dec 2023 · PDF
Canavan GTx BBP-812 - Neurology for Science 2023 - CANaspire Phase 1/2 Study
PRESENTATION · Dec 2023 · PDF
Acoramidis - October 2023 - 4 Year Update from OLE Phase 2 Study
PRESENTATION · Dec 2023 · PDF
Infigratinib - ENDO 2023 - Updated Six Month Results in Phase 2 Cohort 5 Study
PRESENTATION · Dec 2023 · PDF
Encaleret - ADH1 - ASBMR 2023 Mineral Normalization in Phase 2b
PRESENTATION · Dec 2023 · PDF